Literature DB >> 28873507

Borrelia burgdorferi outer surface protein C (OspC) binds complement component C4b and confers bloodstream survival.

Jennifer A Caine1, Yi-Pin Lin2,3, Julie R Kessler4, Hiromi Sato4, John M Leong2, Jenifer Coburn1,4.   

Abstract

Borrelia burgdorferi (Bb) is the causative agent of Lyme disease in the United States, a disease that can result in carditis, and chronic and debilitating arthritis and/or neurologic symptoms if left untreated. Bb survives in the midgut of the Ixodes scapularis tick, or within tissues of immunocompetent hosts. In the early stages of infection, the bacteria are present in the bloodstream where they must resist clearance by the innate immune system of the host. We have found a novel role for outer surface protein C (OspC) from B. burgdorferi and B. garinii in interactions with the complement component C4b and bloodstream survival in vivo. Our data show that OspC inhibits the classical and lectin complement pathways and competes with complement protein C2 for C4b binding. Resistance to complement is important for maintenance of the lifecycle of Bb, enabling survival of the pathogen within the host as well as in the midgut of a feeding tick when ospC expression is induced.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  Borrelia; C4b; OspC; complement; immunity; infection

Mesh:

Substances:

Year:  2017        PMID: 28873507      PMCID: PMC5680108          DOI: 10.1111/cmi.12786

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  61 in total

1.  Lack of a role for iron in the Lyme disease pathogen.

Authors:  J E Posey; F C Gherardini
Journal:  Science       Date:  2000-06-02       Impact factor: 47.728

2.  Differential survival of Lyme borreliosis spirochetes in ticks that feed on birds.

Authors:  Klaus Kurtenbach; Stefanie M Schäfer; Henna-Sisko Sewell; Mick Peacey; Andrew Hoodless; Patricia A Nuttall; Sarah E Randolph
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

3.  The OspE-related proteins inhibit complement deposition and enhance serum resistance of Borrelia burgdorferi, the lyme disease spirochete.

Authors:  Melisha R Kenedy; Darrin R Akins
Journal:  Infect Immun       Date:  2011-01-31       Impact factor: 3.441

4.  A short-term Borrelia burgdorferi infection model identifies tissue tropisms and bloodstream survival conferred by adhesion proteins.

Authors:  Jennifer A Caine; Jenifer Coburn
Journal:  Infect Immun       Date:  2015-05-26       Impact factor: 3.441

5.  Immunological and molecular polymorphisms of OspC, an immunodominant major outer surface protein of Borrelia burgdorferi.

Authors:  B Wilske; V Preac-Mursic; S Jauris; A Hofmann; I Pradel; E Soutschek; E Schwab; G Will; G Wanner
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

6.  In vitro CpG methylation increases the transformation efficiency of Borrelia burgdorferi strains harboring the endogenous linear plasmid lp56.

Authors:  Qiang Chen; Joshua R Fischer; Vivian M Benoit; Nicholas P Dufour; Philip Youderian; John M Leong
Journal:  J Bacteriol       Date:  2008-10-10       Impact factor: 3.490

7.  Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis.

Authors:  A P van Dam; H Kuiper; K Vos; A Widjojokusumo; B M de Jongh; L Spanjaard; A C Ramselaar; M D Kramer; J Dankert
Journal:  Clin Infect Dis       Date:  1993-10       Impact factor: 9.079

8.  Contribution of the infection-associated complement regulator-acquiring surface protein 4 (ErpC) to complement resistance of Borrelia burgdorferi.

Authors:  Claudia Hammerschmidt; Teresia Hallström; Christine Skerka; Reinhard Wallich; Brian Stevenson; Peter F Zipfel; Peter Kraiczy
Journal:  Clin Dev Immunol       Date:  2012-01-30

9.  The inhibition of plasmin, plasma kallikrein, plasma permeability factor, and the C'1r subcomponent of the first component of complement by serum C'1 esterase inhibitor.

Authors:  O D Ratnoff; J Pensky; D Ogston; G B Naff
Journal:  J Exp Med       Date:  1969-02-01       Impact factor: 14.307

10.  In Vivo Imaging Demonstrates That Borrelia burgdorferi ospC Is Uniquely Expressed Temporally and Spatially throughout Experimental Infection.

Authors:  Jonathan T Skare; Dana K Shaw; Jerome P Trzeciakowski; Jenny A Hyde
Journal:  PLoS One       Date:  2016-09-09       Impact factor: 3.240

View more
  35 in total

1.  Blood treatment of Lyme borreliae demonstrates the mechanism of CspZ-mediated complement evasion to promote systemic infection in vertebrate hosts.

Authors:  Ashley L Marcinkiewicz; Alan P Dupuis; Maxime Zamba-Campero; Nancy Nowak; Peter Kraiczy; Sanjay Ram; Laura D Kramer; Yi-Pin Lin
Journal:  Cell Microbiol       Date:  2019-01-07       Impact factor: 3.715

Review 2.  Complement Evasion Contributes to Lyme Borreliae-Host Associations.

Authors:  Yi-Pin Lin; Maria A Diuk-Wasser; Brian Stevenson; Peter Kraiczy
Journal:  Trends Parasitol       Date:  2020-05-23

Review 3.  Complement Evasion by Lyme Disease Spirochetes.

Authors:  Jon T Skare; Brandon L Garcia
Journal:  Trends Microbiol       Date:  2020-05-29       Impact factor: 17.079

4.  Effects of Immunomodulatory Drug Fingolimod (FTY720) on Chlamydia Dissemination and Pathogenesis.

Authors:  Zengzi Zhou; Lingxiang Xie; Luying Wang; Min Xue; Dabao Xu; Guangming Zhong
Journal:  Infect Immun       Date:  2020-10-19       Impact factor: 3.441

5.  BBB07 contributes to, but is not essential for, Borrelia burgdorferi infection in mice.

Authors:  Beth Hahn; Phillip Anderson; Zouyan Lu; Rebecca Danner; Zhipeng Zhou; Noorie Hyun; Lihui Gao; Tao Lin; Steven J Norris; Jenifer Coburn
Journal:  Microbiology (Reading)       Date:  2020-10       Impact factor: 2.777

6.  Characterization of Stress and Innate Immunity Resistance of Wild-Type and Δp66 Borrelia burgdorferi.

Authors:  Michael W Curtis; Beth L Hahn; Kai Zhang; Chunhao Li; Richard T Robinson; Jenifer Coburn
Journal:  Infect Immun       Date:  2018-01-22       Impact factor: 3.441

7.  Non-anticoagulant Heparin as a Pre-exposure Prophylaxis Prevents Lyme Disease Infection.

Authors:  Yi-Pin Lin; Yanlei Yu; Ashley L Marcinkiewicz; Patricia Lederman; Thomas M Hart; Fuming Zhang; Robert J Linhardt
Journal:  ACS Infect Dis       Date:  2020-01-30       Impact factor: 5.084

8.  Plasticity in early immune evasion strategies of a bacterial pathogen.

Authors:  Quentin Bernard; Alexis A Smith; Xiuli Yang; Juraj Koci; Shelby D Foor; Sarah D Cramer; Xuran Zhuang; Jennifer E Dwyer; Yi-Pin Lin; Emmanuel F Mongodin; Adriana Marques; John M Leong; Juan Anguita; Utpal Pal
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-02       Impact factor: 11.205

Review 9.  Lyme Disease Frontiers: Reconciling Borrelia Biology and Clinical Conundrums.

Authors:  Vladimir V Bamm; Jordan T Ko; Iain L Mainprize; Victoria P Sanderson; Melanie K B Wills
Journal:  Pathogens       Date:  2019-12-16

Review 10.  Outer surface protein polymorphisms linked to host-spirochete association in Lyme borreliae.

Authors:  Danielle M Tufts; Thomas M Hart; Grace F Chen; Sergios-Orestis Kolokotronis; Maria A Diuk-Wasser; Yi-Pin Lin
Journal:  Mol Microbiol       Date:  2019-02-27       Impact factor: 3.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.